Video

Dr. Nanus on Managing Side Effects from Immunotherapy in RCC

David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses managing side effects from immunotherapy in renal cell carcinoma (RCC).

David M. Nanus, MD, medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, discusses managing side effects from immunotherapy in renal cell carcinoma (RCC).

More oncologists are recognizing immune-related side effects of patients being treated with immunotherapy as the treatment becomes more widely available. For patients with RCC, the more prevalent side effects are rashes, nephritis, hepatitis, and adrenal insufficiency, Nanus says.

The community is gaining a better understanding of these side effects, but medical professionals who do not often deal with these drugs, may not know what to do when a patient with cancer being treated on immunotherapy presents with fatigue. Nanus says that internists and other non-oncologists must be aware of these side effects. Additionally, patients should seek counsel from their medical oncologists if they are observing concerning immune-related side effects .

Related Videos
Jennifer Scalici, MD
Steven H. Lin, MD, PhD
Anna Weiss, MD, associate professor, Department of Surgery, Oncology, associate professor, Cancer Center, University of Rochester Medicine
Roy S. Herbst, MD, PhD, Ensign Professor of Medicine (Medical Oncology), professor, pharmacology, deputy director, Yale Cancer Center; chief, Hematology/Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; assistant dean, Translational Research, Yale School of Medicine
Victor Moreno, MD, PhD
Tiago Biachi, MD, PhD
Dr Girard on De Novo and Acquired Resistance Alterations in HER2-Altered NSCLC
Elias Jabbour, MD
Daniel DeAngelo, MD, PhD
Douglas W. Sborov, MD, MS